(Total Views: 633)
Posted On: 06/04/2022 2:57:47 AM
Post# of 148899
Mgk, the trial we're doing with Anderson Center is this one:
announced here: https://www.globenewswire.com/news-release/20...e-ICB.html
The PR doesn't say anything about metastasis to the brain.
FYI, Ohm believes (and the odds say he is right) that combining ICB (immune checkpoint blockade) with Leron is redundant -- Leron doesn't need the help.
Quote:
Clinical Trial Development Targeting Triple-Negative Breast Cancer (TNBC) to Evaluate Anti-Tumor Effects and Identify Immunological Biomarkers for Leronlimab in Combination with Immune Checkpoint Blockade
announced here: https://www.globenewswire.com/news-release/20...e-ICB.html
The PR doesn't say anything about metastasis to the brain.
FYI, Ohm believes (and the odds say he is right) that combining ICB (immune checkpoint blockade) with Leron is redundant -- Leron doesn't need the help.
(4)
(0)Scroll down for more posts ▼
